CBD May Not Be A Cure For Coronavirus, But It Offers Anti-viral, Anti-Inflammatory And Anti-Bacterial Properties
CBD may not in itself offer a cure for the devastating coronavirus, but it offers helpful properties that address key elements. CBD is known to offer anti-viral, anti-inflammatory and anti-bacterial properties. It also acts as an effective treatment for nausea and vomiting, which can be induced by the coronavirus.
The impact of the coronavirus globally has also intensified coverage of CBD. Companies such as stockmarketpress.com features coverage of CBD related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF) and OrganiGram Holdings Inc. (NASDAQ: OGI).
CBD May Not Be A Cure For Coronavirus, But It Offers Antiviral, Anti-Inflammatory And Anti-Bacterial Properties
The impact of the coronavirus has been devastating to travel, hotels, cruises, financial markets and manufacturing throughout the world. Last week, stocks fell on the S&P greater than 12%. The Industrials fell to a little more than 25,000 points last week. It has now infected some 87,000 people globally and killed more than 3,000 worldwide, including 1,100 in China alone. The U.S. has reported its first corona virus related death. The coronavirus (COVID19) could become a worldwide pandemic. CBD may have a role to play in consumers who contract the virus. CBD may not be a cure for coronavirus, but it offers anti-viral, anti-inflammatory and anti-bacterial properties.
The Properties Of CBD Related To The Coronavirus
CBD is not seen as a cure for the coronavirus, but it has numerous important properties that address issues felt by individuals who contract the illness, experts said. CBD may not be a cure for coronavirus, but it offers anti-viral, anti-inflammatory and anti-bacterial properties. These are significant for people who contract the coronavirus and become nauseas, vomit, and experience any inflammation. Also, CBD is known to reduce stress and anxiety issues. All of these properties are helpful in fighting the disease.
High Quality Product Is Especially Important When Taking CBD
CBD Unlimited, Inc. (OTC PINK: EDXC) offers the highest quality CBD is multiple forms by using a quality control seed-to-shelf strategy that gives it compete control over the growth, processing and marketing of CBD product. CBD Unlimited, Inc. (OTC PINK: EDXC) in 2019 placed product on greater than 5,000+ mass market shelves, including pharmacies. CBD Unlimited, Inc. (OTC PINK: EDXC) is aggressively pursuing more market share in this quick-growing marketplace. CBD use as a supplement is higher than first believed, great news for companies such as CBD Unlimited, Inc. (OTC PINK: EDXC).
CBD Research Indicates A U.S. Market Of $16 Billion Is Coming, Positive News For Companies Such As CBD Unlimited, Inc. (OTC PINK: EDXC)
In this fast-growing marketplace, CBD-buying consumers are facing new brands, safety and health claims and a variety of not well known manufacturers. As they face this tangle of CBD offerings, it is the CBD companies which need to further educate them on high quality product. U.S. News & World Report reports monthly Google CBD inquiry hits at 6.4 million, surpassing almost any other health topic or product. Consumers are eager to learn more the properties of CBD and its qualities.
CBD Unlimited, Inc. (OTC PINK: EDXC) Offers Highest Quality CBD
CBD Unlimited, Inc. (OTC PINK: EDXC) makes sure its CBD products are highest quality, American-manufactured and tightly controlled by a seed-to-shelf strategy, meaning its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent Corporate Presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. Product is cGMP Certified (Good Manufacturing Practice Certification). CBD may not be a cure for coronavirus, but it offers anti-viral, anti-inflammatory and anti-bacterial properties. It offers CBD products for both humans and pet consumables.
Research company Cowen & Co. sees CBD use growing conservatively to 10% of U.S. consumers by 2025. That means 25 million American consumers will be using CBD by then — implying a market of $16 billion, it said. Analyst firm Jeffries estimates that CBD market will reach $130 billion globally by 2029.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Stock Market Press
110 Wall St.
New York, NY 10005 email@example.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press